During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Localization of activated natural killer (A-NK) cells in the microvasculature of growing tumors is the result of recognition of the intracellular and vascular cell-adhesion molecules ICAM-1 and VCAM-1 on the tumor endothelium, mediated by lymphocyte function-associated protein LFA-1 and vascular lymphocyte function-associated protein VLA-4. In vitro and in vivo studies of A-NK cell adhesion to endothelial cells showed that vascular endothelial growth factor (VEGF) promotes adhesion, whereas basic fibroblast growth factor (bFGF) inhibits adhesion through the regulation of these molecules on tumor vasculature. Thus, some angiogenic factors may facilitate lymphocyte recognition of angiogenic vessels, whereas others may provide such vessels with a mechanism that protects them from cytotoxic lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Angiogenic molecules present in the TME, such as VEGF (FIG. 1), can control the trafficking of immune cells to the tumour by altering the expression of adhesion molecules, including the integrin ligands intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion protein 1 (VCAM1), on endothelial cells (ECs) and immune cells10,14,15”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [14]
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Self-citationDefinition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Busch, H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00015 · Cited by 1,205
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Leukocyte adhesion to endothelium in inflammation
Osborn, L. (1990) · Cell · doi:10.1016/0092-8674(90)90230-c · Cited by 865
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., & Polverini, P. J. (1995) · Nature · doi:10.1038/376517a0 · Cited by 600
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.
de Fougerolles, A. R., Stacker, S. A., Schwarting, R., & Springer, T. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.253 · Cited by 495
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
Self-citation
Research works printed but not linked: 2
- Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
- Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
Cited by
Items 201–300 of 482
Ojwang, L. O., Banerjee, N., Noratto, G. D., Angel‐Morales, G., Hachibamba, T., Awika, J. M., & Mertens‐Talcott, S. U. (2014) · Food & Function · doi:10.1039/c4fo00459k · Cited by 61
CD18 and ICAM-1-Dependent Corneal Neovascularization and Inflammation after Limbal Injury
Moromizato, Y., Stechschulte, S., Miyamoto, K., Murata, T., Tsujikawa, A., Joussen, A. M., & Adamis, A. P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64643-3 · Cited by 60
Flaxenburg, J. A., Melter, M., Lapchak, P. H., Briscoe, D. M., & Pal, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7503 · Cited by 60
Vascular Endothelial Growth Factor: An Important Angiogenic Mediator in Bladder Cancer
CREW, J. P. (1999) · European Urology · doi:10.1159/000019811 · Cited by 59
Lai, W. K., & Adams, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.008 · Cited by 58
Tumor blood vessels, a difficult hurdle for infiltrating leukocytes
Castermans, K., & Griffioen, A. W. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.005 · Cited by 57
Vinores, S. A., Wang, Y., Vinores, M. A., Derevjanik, N. L., Shi, A., Klein, D. A., Detrick, B., & Hooks, J. J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00374-5 · Cited by 56
Okano, H., Onmori, R., Tomita, N., & Ikada, Y. (2006) · Bioelectromagnetics · doi:10.1002/bem.20246 · Cited by 56
“Angiogenesis, the sprouting of new blood vessels, has become an important area of scientific research due to its involvement in various physiological and pathological processes [Ingber et al., 1990; Folkman, 1990, 1992; Folkman and Ingber, 1992; Leunig et al., 1992; Reynolds et al., 1992, 2002; Battegay, 1995; Arbiser…”
BackgroundTumor Vascular Endothelium: Barrier or Target in Tumor Directed Drug Delivery and Immunotherapy
Molema, G., de Leij, L. F. M. H., & Meijer, D. K. F. (1997) · Pharmaceutical Research · doi:10.1023/a:1012038930172 · Cited by 56
Mutually Supportive Mechanisms of Inflammation and Vascular Remodeling
Whiteford, J. R., Rossi, G. D., & Woodfin, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.001 · Cited by 55
Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration
Steege, J. C. A. B.-T., Baeten, C. I. M., Thijssen, V. L. J. L., Satijn, S. A., Verhoeven, I. C. L., Hillen, H. F. P., Wagstaff, J., & Griffioen, A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0742 · Cited by 51
Overcoming physical stromal barriers to cancer immunotherapy
Chung, S. W., Xie, Y., & Suk, J. S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01036-y · Cited by 54
Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
Huang, Y., Fan, H., & Ti, H. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100902 · Cited by 54
Irjala, H., Salmi, M., Alanen, K. A., Grenman, R. A., & Jalkanen, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6937 · Cited by 53
Flati, V., Pastore, L., Griffioen, A. W., Satijn, S., Tomato, E., D’Alimonte, I., LAGLIA, E., Marchetti, P., Gulino, A., & Martinotti, S. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900406 · Cited by 52
Basic Fibroblast Growth Factor Is Expressed by CD19/CD11c-Positive Cells in Hairy Cell Leukemia
Grüber, G., Schwarzmeier, J. D., Shehata, M. M., Hilgarth, M., & Berger, R. (1999) · Blood · doi:10.1182/blood.v94.3.1077.415k06_1077_1085 · Cited by 52
Ortéga, N., Jonca, F., Vincent, S., Favard, C., Ruchoux, M., & Plouët, J. (1997) · Europe PMC (PubMed Central) · Cited by 52
Borrelli, M. J., Schoenherr, D., Wong, A., Bernock, L. J., & Corry, P. M. (2001) · PubMed · Cited by 51
Kamiyama, H., Takano, S., Ishikawa, E., Tsuboi, K., & Matsumura, A. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.2111 · Cited by 50
Bruneau, S., Woda, C. B., Daly, K. P., Boneschansker, L., Jain, N. G., Kochupurakkal, N. M., Contreras, A. G., Seto, T., & Briscoe, D. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00054 · Cited by 52
“In addition,VEGF induces the expression of adhesion molecules and chemokines in (Melder et al.,1996;Marumo et al.,1999;Kim et al.,2001;Rein-ders et al., 2003a; Boulday et al., 2006), and classically enhances vascular permeability (Brown et al., 1997; Basu et al., 2001).”
BackgroundInfluentialFearnley, G. W., Odell, A. F., Latham, A. M., Mughal, N. A., Bruns, A. F., Burgoyne, N. J., Homer‐Vanniasinkam, S., Zachary, I. C., Hollstein, M. C., Wheatcroft, S. B., et al. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0962 · Cited by 49
Quantification of murine endothelial cell adhesion molecules in solid tumors
Langley, R. R., Russell, J., Eppihimer, M. J., Alexander, S., Gerritsen, M. E., Specian, R. D., & Granger, D. N. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h1156 · Cited by 49
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors
Chambers, A., Kundranda, M. N., Rao, S. K., Mahmoud, F. A., & Niu, J. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01099-7 · Cited by 48
Tabruyn, S. P., Sabatel, C., Nguyen, N.-Q.-N., Verhaeghe, C., Castermans, K., Malvaux, L., Griffioen, A. W., MARTIAL, J. A., & Struman, I. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0021 · Cited by 48
Au, P., Tam, J., Duda, D. G., Lin, P., Munn, L. L., Fukumura, D., & Jain, R. K. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080887 · Cited by 48
Self-citationOhno, T., Igarashi, H., Inoue, K., Akazawa, K., Joh-o, K., & Hara, T. (2000) · European Journal of Pediatrics · doi:10.1007/s004310051300 · Cited by 48
A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model
Suzaki, Y., Hamada, K., Sho, M., Ito, T., Miyamoto, K., Akashi, S., Kashizuka, H., Ikeda, N., Nakajima, Y., Iwase, M., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.052 · Cited by 48
Sheikh, S., Parhar, R. S., Kwaasi, A. A. A., Collison, K. S., Yacoub, M. H., Stern, D. M., & Al-Mohanna, F. A. (2000) · Transplantation · doi:10.1097/00007890-200009270-00009 · Cited by 48
Son, B., Kim, M., Won, H., Jung, A., Kim, J., Koo, Y., Lee, N. K., Baek, S.-H., Han, U., Park, C. G., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02053-4 · Cited by 47
Solanilla, A., Villeneuve, J., Auguste, P., Hugues, M., Alioum, A., Lepreux, S., Ducroix, J. P., Duhaut, P., Conri, C., Viallard, J.-F., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep154 · Cited by 47
Retinal Endothelial Angiogenic Activity: Effects of Hypoxia and Glial (Müller) Cells
Yafai, Y., Iandiev, I., Wiedemann, P., Reichenbach, A., & Eichler, W. (2004) · Microcirculation · doi:10.1080/10739680490503375 · Cited by 47
Mäenpää, A., Kovanen, P. E., Paetau, A. E., Jääskeläine, J., & Timonen, T. T. (1997) · Acta Neuropathologica · doi:10.1007/s004010050696 · Cited by 47
Wang, K., Liu, C., Wu, Y., Yu-ling, F., & Bai, H.-L. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0048-4 · Cited by 46
ANGIOGENESIS IN THE huPBL-SCID MODEL OF HUMAN TRANSPLANT REJECTION1
Moulton, K. S., Melder, R. J., Dharnidharka, V. R., Hardin-Young, J., Jain, R. K., & Briscoe, D. M. (1999) · Transplantation · doi:10.1097/00007890-199906270-00020 · Cited by 44
Self-citationLymphatic endothelium: An important interactive surface for malignant cells
Farnsworth, R. H., Achen, M. G., & Stacker, S. A. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.02.003 · Cited by 45
Tumor microvasculature as a barrier to antitumor immunity
Chen, Q., Wang, W., & Evans, S. S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0425-4 · Cited by 45
Dual Role of Vascular Endothelial Growth Factor in Hepatic Ischemia-Reperfusion Injury
Tsurui, Y., Sho, M., Kuzumoto, Y., Hamada, K., Akashi, S., Kashizuka, H., Ikeda, N., Nomi, T., Mizuno, T., Kanehiro, H., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000161627.84481.5e · Cited by 45
Liu, Z., Liu, X., Bao, L., Liu, J., Zhu, X., Mo, X., & Tang, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120999 · Cited by 44
Faridi, A., Rudlowski, C., Biesterfeld, S., Schuh, S., Rath, W. H., & Schroder, W. (2002) · Pathology - Research and Practice · doi:10.1078/0344-0338-00176 · Cited by 44
Vascular Endothelial Growth Factor Molecular and Biological Aspects
Ferrara, N., & Gerber, H. P. (1999) · Advances in organ biology · doi:10.1016/s1569-2590(08)60162-7 · Cited by 44
Autoaggression and tumor rejection: it takes more than self‐specific T‐cell activation
Ganß, R., Limmer, A., Sacher, T., Arnold, B., & Hämmerling, G. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01321.x · Cited by 43
Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix
Ortéga, N., L'Faqihi, F., & Plouët, J. (1998) · Biology of the Cell · doi:10.1111/j.1768-322x.1998.tb01047.x · Cited by 42
Insulin resistance in vascular endothelial cells promotes intestinal tumour formation
Wang, X., Häring, M.-F., Rathjen, T., Lockhart, S. M., Sørensen, D., Ussar, S., Rasmussen, L. M., Bertagnolli, M. M., Kahn, C. R., & Rask‐Madsen, C. (2017) · Oncogene · doi:10.1038/onc.2017.107 · Cited by 41
Circulating biomarkers of bevacizumab activity in patients with breast cancer
Denduluri, N., Yang, S. X., Berman, A. W., Nguyen, D., Liewehr, D. J., Steinberg, S. M., & Swain, S. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.1.5337 · Cited by 41
Vascular endothelial growth factor gene regulation and action in diabetic retinopathy
LU, M., & ADAMIS, A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(01)00010-4 · Cited by 41
“Furthermore, endothelial cell ICAM-1 is induced by conditions and factors associated with diabetic retinopathy, such as hypoxia [15], hyperglycemia [101], AGE [109], shear stress [80], and the peptides VEGF (vascular endothelial growth factor) [66] and TNF [28].”
BackgroundSivridis, E., Giatromanolaki, A. N., Papadopoulos, I., Gatter, K. C., Harris, A. L., & Koukourakis, M. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600281 · Cited by 41
Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
Kim, K.-S., Kim, D., & Kim, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040525 · Cited by 40
Ferreira, I. G., Pucca, M. B., de Oliveira, I. S., Cerni, F. A., Jacob, B. D. C. D. S., & Arantes, E. C. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.05.003 · Cited by 40
Angiogenesis induced by tumor necrosis factor-agr; is mediated by α4 integrins
Vanderslice, P., Munsch, C. L., Rachal, E., Erichsen, D. A., Sughrue, K. M., Truong, A. N., Wygant, J. N., McIntyre, B. W., Eskin, S. G., Tilton, R. G., et al. (1998) · Angiogenesis · doi:10.1023/a:1009296700991 · Cited by 40
“TNF-a induces VCAM-1 expression on the surface of endothelial cells(12) whereas FGF-2 does not.(21) Since a soluble form of VCAM-1 previously has been demonstrated to induce endothelial cell migration,(14) levels of sVCAM-1 in culture media from cells treated with TNF-a were determined.”
BackgroundDaniilidou, K., Frangou-Plemenou, M., Grammatikakis, J., Grigoriou, O., Vitoratos, N., & Kondi-Pafiti, A. I. (2013) · PubMed · Cited by 38
Dewhirst, M. W., Shan, S., Cao, Y., Moeller, B. J., Yuan, F., & Li, C. (2002) · Disease Markers · doi:10.1155/2002/820102 · Cited by 38
Human NK Cells Lyse Organ-Specific Endothelial Cells: Analysis of Adhesion and Cytotoxic Mechanisms
Bielawska‐Pohl, A., Silva, C. C. D., Caignard, A., Gaudin, C., Duś, D., Kiéda, C., & Chouaïb, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5573 · Cited by 38
Tumor Angiogenesis, Macrophages, and Cytokines
Bando, H., & Toi, M. (2000) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4221-6_21 · Cited by 38
Emerging avenues linking inflammation, angiogenesis and Sjögren’s syndrome
Lisi, S., Sisto, M., D’Amore, M., Lofrumento, D. D., & Ribatti, D. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.021 · Cited by 37
IL-12 Promotes the Adhesion of NK Cells to Endothelial Selectins Under Flow Conditions
Yago, T., Tsukuda, M., Fukushima, H., Yamaoka, H., Kurata-Miura, K., Nishi, T., & Minami, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1140 · Cited by 37
Biological Insight and Recent Advancement in the Treatment of Neuroblastoma
Rivera, Z., Escutia, C., Madonna, M. B., & Gupta, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108470 · Cited by 36
“VEGF VEGF acts as a pro-inflammatory cytokine by increasing endothelial cell permeability, by inducing the expression of endothelial cell adhesion molecules, and via its ability to act as a monocyte chemo-attractant [71].”
BackgroundEdelbauer, M., Datta, D., Vos, I. H. C., Basu, A., Stack, M. P., Reinders, M. E. J., Sho, M., Calzadilla, K., Ganz, P., & Briscoe, D. M. (2010) · Blood · doi:10.1182/blood-2009-11-252460 · Cited by 33
The Molecular Biology of Peritoneal Carcinomatosis from Gastrointestinal Cancer
Jayne, D. G. (2003) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v32n2p219 · Cited by 35
Vaccination approach to anti-angiogenic treatment of cancer
Wentink, M. Q., Huijbers, E. J. M., de Gruijl, T. D., Verheul, H. M. W., Olsson, A., & Griffioen, A. W. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.01.005 · Cited by 34
Ismail, H., Mofarrahi, M., Echavarría, R., Harel, S., Verdin, E. M., Lim, H. W., Jin, Z., Sun, J., Zeng, H., & Hussain, S. N. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251546 · Cited by 34
In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis.
Becker, Kruse, F., Azzam, L., Nobiling, R., Reichling, J., & Völcker, H. E. (1999) · PubMed · Cited by 34
Angiogenesis and Lymphangiogenesis in Tumors: Insights from Intravital MicroscopyPreprint
JAIN, R. K. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.239 · Cited by 34
Self-citationRossato, F. A., Su, Y., Mackey, A. M., & Ng, Y. (2020) · Cells · doi:10.3390/cells9092057 · Cited by 33
Khachigian, L. M., Varcoe, R. L., Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318902 · Cited by 33
Nakajima, K., Tabata, S., Yamashita, T., Kusuhara, M., Arakawa, K., Ohmori, R., Yonemura, A., Higashi, K., Ayaori, M., Nakamura, H., et al. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270509 · Cited by 33
Icam-1 and acute pancreatitis complicated by acute lung injury.
Zhang, X., Wu, D., & Jiang, X. (2009) · PubMed · Cited by 33
Angiogenesis modulates the tumour immune response
Griffioen, A. W., Tromp, S. C., & Hillen, H. F. P. (1998) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1998.00091.x · Cited by 33
“However, in an in vivo situation the net result of angiogenic stimulation is a reduction in leucocyte–endothelium interactions (Melder et al. 1996).”
BackgroundJohansson, M., Henriksson, R., Bergenheim, A. T., & Koskinen, L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1354 · Cited by 33
Melder, R. J., Munn, L. L., Stoll, B. R., Marecos, E., Baxter, L. T., Weissleder, R., & Jain, R. K. (2002) · Neoplasia · doi:10.1038/sj.neo.7900209 · Cited by 33
Self-citationAnthony, C., Mladkova-Suchy, N., & Adamson, D. C. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1650019 · Cited by 32
“Additionally, it increases vascular permeability, promotes leukocyte adhesion in inflammation by inducing expression of various adhesion molecules [15], and”
BackgroundTsai, H., Yang, I., Lin, C., Chai, C., Huang, Y., Chen, C., Hou, M., Kuo, C., Juo, S. H., & Wang, J. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1570-z · Cited by 32
Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis
Ferrara, N. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-453-5_8 · Cited by 32
MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response
Matejuk, A., Collet, G., Nadim, M., Grillon, C., & Kieda, C. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0231-4 · Cited by 30
Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper
Avitabile, T., Azzolini, C., Bandello, F. M., Boscia, F., Falco, S. D., Fornasari, D., Lanzetta, P., Mastropasqua, L., Midena, E., Ricci, F., et al. (2017) · European Journal of Ophthalmology · doi:10.5301/ejo.5001053 · Cited by 30
Ascherl, G., Sgadari, C., Bugarini, R., Bogner, J. R., Schatz, O., Ensoli, B., & Stürzl, M. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201300343717 · Cited by 30
Liu, N., Liu, J., Ji, Y., & Lu, P. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303052 · Cited by 29
Torres‐García, D., Pérez‐Torres, A., Manoutcharian, K., Orbe, U., Servín-Blanco, R., Fragoso, G., & Sciutto, E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.060 · Cited by 29
Umemoto, E., Takeda, A., Jin, S., Luo, Z., Nakahogi, N., Hayasaka, H., Lee, C. M., Tanaka, T. T., & Miyasaka, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083681 · Cited by 28
Tognarelli, S., Gayet, J., Lambert, M., Dupuy, S., Karras, A., Cohen, P., Guillevin, L., de Menthon, M., & Caillat‐Zucman, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301508 · Cited by 28
Sterner, E., Masuko, S., Li, G.-Y., Li, L.-Y., Green, D. E., Otto, N. J., Xu, Y.-M., DeAngelis, P., Liu, J., Dordick, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.546937 · Cited by 24
Aoki, M., Kanamori, M., Yudoh, K., Ohmori, K., Yasuda, T., & Kimura, T. (2001) · Tumor Biology · doi:10.1159/000050622 · Cited by 28
Bispecific antibodies for treatment of cancer in experimental animal models and man
Kroesen, B. J., Helfrich, W., Molema, G., & de Leij, L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00096-3 · Cited by 28
Surrogate Markers of Tumoral Angiogenesis
Byrne, G. J., & Bundred, N. J. (2000) · The International Journal of Biological Markers · doi:10.1177/172460080001500411 · Cited by 27
Vascular endothelial growth factor is associated with histological instability of carotid plaques
Russell, D., Abbott, C. R., & Gough, M. J. (2008) · British journal of surgery · doi:10.1002/bjs.6100 · Cited by 26
Expression of Endothelial Cell Adhesion Molecules in Neovascularized Tissue
VALLIEN, G., Langley, R. R., Jennings, S. R., Specian, R. D., & Granger, D. N. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00125.x · Cited by 26
Angiogenesis, a target for tumor therapy
Griffioen, A. W., Barendsz-Janson, A. F., Mayo, K. H., & Hillen, H. F. P. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90106-8 · Cited by 26
Raidl, M., Sibbing, B., Strauch, J., Müller, K., Nemat, A., Schneider, P. M., Hag, H., Erdmann, E., & Koch, A. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0043-4 · Cited by 25
Benton, R., Maddie, M. A., Gruenthal, M. J., Hagg, T., & Whittemore, S. R. (2009) · Current Neurovascular Research · doi:10.2174/156720209788185678 · Cited by 24
Vascular endothelial growth factor inhibition: Conflicting roles in tumor growth
Saranadasa, M., & Wang, E. S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.06.012 · Cited by 24
Sa, V., Wh, X., Zimmerman, R., Whitcup, S. M., & Wawrousek, E. F. (2003) · PubMed · doi:10.14670/hh-18.797 · Cited by 24
Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells
Hashemi, G., Dight, J., Khosrotehrani, K., & Sormani, L. (2022) · Cancers · doi:10.3390/cancers14174216 · Cited by 23
Targeting the intragraft microenvironment and the development of chronic allograft rejection
Dormond, O., Dufour, M., Seto, T., Bruneau, S., & Briscoe, D. M. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.334 · Cited by 24
O’Toole, E. A., & Mellerio, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch14 · Cited by 23
Cullen, V., Mackarel, A. J., Hislip, S. J., O'CONNOR, C. M., & KEENAN, A. K. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00102-1 · Cited by 23
Cebeci, Z., & Kır, N. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s73540 · Cited by 22
Zhu, N., Weng, S., Wang, J., Chen, J., Yu, L., Fang, X., & Yuan, Y. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03044-5 · Cited by 22
Valcárcel, M., Mendoza, L., Hernández, J. M. E., Carrascal, T., Salado, C., Crende, O., & Vidal‐Vanaclocha, F. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-142 · Cited by 22
Current and future pharmacological intervention for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.441 · Cited by 22
Vinores, S. A., Derevjanik, N. L., Vinores, M. A., Okamoto, N., & Campochiaro, P. A. (2000) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4221-6_11 · Cited by 22
Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases
Winlaw, D. S. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00716-9 · Cited by 22
“Angiogenic cytokines may also alter the immune response by modulating the expression of adhesion molecules on tumor endothelium [62].”
Background
Metadata
- Authors
- Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 992-997
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W304295984
- Cited by
- 451
- References
- 39
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 9
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32ca061631-01a2)
- National Cancer Institute (F32-CA 61631, R35CA056591, R35-CA-56591)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- natural killer cells, tumor endothelium, angiogenesis, vascular endothelial growth factor, basic fibroblast growth factor, cell adhesion, ICAM-1, VCAM-1, LFA-1, VLA-4, tumor vasculature, cytotoxic lymphocytes
- MeSH terms
- Animals, Cell Adhesion, Endothelium, Vascular, Humans, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Tumor Cells, Cultured, Killer Cells, Lymphokine-Activated, Lymphocyte Function-Associated Antigen-1, Fibroblast Growth Factor 2, Endothelial Growth Factors, Mice, SCID, Intercellular Adhesion Molecule-1, P-Selectin, Vascular Cell Adhesion Molecule-1, E-Selectin, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.